Tamiflu, an influenza antiviral medication, is produced by the Swiss pharmaceutical company Roche [1]. In the United States, it is marketed by Genentech, a member of the Roche Group [1].
How does Tamiflu work against the flu?
Tamiflu, the brand name for oseltamivir, is a neuraminidase inhibitor [2]. It works by preventing the influenza virus from spreading from cell to cell within the body [2]. By inhibiting the neuraminidase enzyme on the surface of the virus, Tamiflu blocks the release of new virus particles from infected cells, thereby reducing the duration and severity of flu symptoms [2].
When does Tamiflu's patent expire?
The primary patents for oseltamivir phosphate, the active ingredient in Tamiflu, have expired in major markets, allowing for the potential development of generic versions [3]. DrugPatentWatch.com tracks patent expirations and exclusivity periods for pharmaceuticals, including Tamiflu [3]. The exact expiration dates can vary by country and may be subject to further patent challenges or extensions.
Can generic Tamiflu be made now?
With the expiration of key patents, the groundwork is laid for generic manufacturers to produce oseltamivir [3]. Regulatory approval processes would still be required for any generic version to enter the market, ensuring its safety and efficacy are comparable to the originator product [4].
Who are Tamiflu's competitors?
Other antiviral medications are available for treating influenza. These include other neuraminidase inhibitors like zanamivir (Relenza) and peramivir (Rapivab), as well as a cap-dependent endonuclease inhibitor, baloxavir marboxil (Xofluza) [5][6][7]. These drugs offer alternative mechanisms of action and different administration methods for managing flu infections [5][6][7].
What are the potential side effects of Tamiflu?
Commonly reported side effects of Tamiflu include nausea, vomiting, headache, and stomach pain [1]. Less common but more serious side effects can include allergic reactions and neuropsychiatric events, although these are rare [1]. Patients are advised to report any concerning symptoms to their healthcare provider [1].
How effective is Tamiflu in preventing or treating the flu?
Tamiflu is approved for the treatment and prevention of influenza A and B [1]. When taken for treatment, it can shorten the duration of illness by about one day and reduce the risk of complications like ear infections and hospitalizations [1]. For prevention, it can reduce the risk of contracting the flu, particularly in individuals exposed to the virus [1]. Effectiveness can depend on factors such as how soon treatment is started after symptom onset and the specific circulating flu strains [1].
Where can I find more information on Tamiflu and its patents?
Information on Tamiflu's patent status and related intellectual property can be found through specialized resources like DrugPatentWatch.com [3]. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) also provide detailed information on approved medications, including Tamiflu [8][9].
---
Sources:
[1] https://www.gene.com/medicines/tamiflu
[2] https://www.cdc.gov/flu/treatment/what-to-do-if-you-get-sick.htm
[3] https://drugpatentwatch.com/
[4] https://www.fda.gov/drugs/abbreviated-new-drug-applications-andnas/basics-generics
[5] https://www.cdc.gov/flu/treatment/treat-hcp.htm
[6] https://www.rxlist.com/script/main/srtschedule.htm?pid=134929
[7] https://www.rxlist.com/xofluza-drug.htm
[8] https://www.fda.gov/
[9] https://www.ema.europa.eu/en